Gita Ramjee

Datos Biográficos

ID	355949
NOMBRE	Gita Ramjee
NOMBRES	Gita
APELLIDO	Ramjee
FIRMA	RAMJEE G
AFILIACIONES	South African Medical Research Council
VERIFICADO	No
TOTAL DE OBRAS	38
TOTAL DE CITAS	24
TOTAL COMO AUTOR	38
TOTAL COMO EDITOR	0
PRIMER AÑO DE PUBLICACIÓN	1998
AÑO MÁS RECIENTE DE PUBLICACIÓN	2023
ÍNDICE H	2

Spatial variations in STIs among women enrolled in HIV prevention clinical trials in Durban, KwaZulu-Natal, South Africa
Open AccessReshmi Dassaye, Handan Wand et al.ARTICLESAHARA-J Journal of Social…2023
South Africa is faced with a high HIV and STI prevalence and incidence, respectively, with pockets of high burden areas driving these diseases. Localised monitoring of the HIV epidemic and STI endemic would enable more effective targeted prevention strategies. We assessed spatial variations in curable STI incidence among a cohort of women enrolled in HIV prevention clinical trials between 2002 and 2012. STI incidence rates from 7557 South African…
Temporal trends in sexual behaviours and their impacts on HIV incidence among South African women
Handan Wand, Tarylee Reddy et al.ARTICLEAIDS Care2021
South Africa has the highest number of HIV infected individuals in the world. The primary objective of the current study was to describe temporal changes in HIV incidence rates using the data from 9,948 women who enrolled in one of the six HIV prevention trials conducted in KwaZulu-Natal, South Africa. Characteristics of the study population were presented and compared across the four study periods: 2002-2004, 2005-2008, 2009-2011 and 2012-2016. …
The Influence of Perceived Dapivirine Vaginal Ring Effectiveness on Social Disclosure and Ring Adherence
Open AccessMarie C D Stoner, Elizabeth R Brown et al.ARTICLEAIDS and Behavior2021
Quantifying Vulnerabilities of Single Women and Sexually Transmitted Infections in South Africa (2002–2016)
Open AccessHandan Wand, Gita Ramjee et al.ARTICLEArchives of Sexual Behavior2021Referencias: 27
Geographical-level contributions of risk factors for HIV infections using generalized additive models
Handan Wand, Reshmi Dassaye et al.ARTICLEAIDS Care2019
South Africa has the highest burden of human immunodeficiency virus (HIV) infections in the world with significant geographical variations. We identified the predictors of HIV infections and their sub-geographical-level contributions to the epidemic using a decade long data (2002-2012) from 6484 South African women. Generalized additive models were used to uncover the most significant features of these estimates across the region. In the overall …
Point-of-care HIV testing best practice for early infant diagnosis
Open AccessElizabeth Spooner, Kerusha Govender et al.ARTICLEBMC Public Health2019
ISRCTN38911104 registered 9 January 2018 - retrospectively registered
Linkage to Care Following an HIV Diagnosis in Three Public Sector Clinics in eThekwini (Durban), South Africa
Open AccessHoffman, Cheng-Shiun Leu et al.ARTICLEAIDS and Behavior2019
“I did not see a need to get tested before, everything was going well with my health”
Shema Tariq, Hoffman et al.ARTICLEAIDS Care2018
Few studies have examined HIV-testing decision-making since the South African national HIV counseling and testing campaign in 2010-2011 and subsequent expansion in antiretroviral therapy (ART) eligibility in 2012. We describe HIV-testing decision-making and pathways to testing among participants in Pathways to Care, a cohort study of newly-diagnosed HIV-positive adults in KwaZulu-Natal. Our analysis is embedded within a theoretical framework info…
Social Support and Violence-prone Relationships as Predictors of Disclosure of HIV Status Among Newly Diagnosed HIV-positive South Africans
Open AccessJocelyn Fifield, Lucia F O’sulliban et al.ARTICLEAIDS and Behavior2018
Research participants' skills development as HIV prevention peer educators in their communities
Open AccessNeetha Shagan Morar, Sarita Naidoo et al.ARTICLEJournal of Health Psychology2018Referencias: 11
This article describes the influence of a peer education programme on skills development among 22 women participating in HIV prevention trials. Interviews were used to collect data on peer educator experiences and their opinions of the trainings. The training enhanced their agency and confidence to engage their family and community on health promotion, including HIV prevention research procedures, thus improving their self-esteem and communicatio…
Prevalent Herpes Simplex Virus-2 Increases the Risk of Incident Bacterial Vaginosis in Women from South Africa
Open AccessNathlee Abbai, Nathlee S Abbai et al.ARTICLEAIDS and Behavior2017
A Simple Risk Prediction Algorithm for HIV Transmission
Open AccessHandan Wand, Tarylee Reddy et al.ARTICLEAIDS and Behavior2017
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women
Jared M Baeten, Thesla Palanee‐phillip et al.ARTICLENew England Journal of Medicine2016
BACKGROUND: Antiretroviral medications that are used as prophylaxis can prevent acquisition of human immunodeficiency virus type 1 (HIV-1) infection. However, in clinical trials among African women, the incidence of HIV-1 infection was not reduced, probably because of low adherence. Longer-acting methods of drug delivery, such as vaginal rings, may simplify use of antiretroviral medications and provide HIV-1 protection. METHODS: We conducted a ph…
Sharing of Investigational Drug Among Participants in the Voice Trial
Open AccessJeeva Moodley, Sarita Naidoo et al.ARTICLEAIDS and Behavior2016
Identifying Factors Associated with Low-Adherence and Subsequent HIV Seroconversions Among South African Women Enrolled in a Biomedical Intervention Trial
Open AccessHandan Wand, Gita RamjeeARTICLEAIDS and Behavior2016
Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women
Jeanne Marrazzo, Jeanne M Marrazzo et al.ARTICLENew England Journal of Medicine2015
BACKGROUND: Reproductive-age women need effective interventions to prevent the acquisition of human immunodeficiency virus type 1 (HIV-1) infection. METHODS: We conducted a randomized, placebo-controlled trial to assess daily treatment with oral tenofovir disoproxil fumarate (TDF), oral tenofovir-emtricitabine (TDF-FTC), or 1% tenofovir (TFV) vaginal gel as preexposure prophylaxis against HIV-1 infection in women in South Africa, Uganda, and Zimb…
Spatial clustering of “measured” and “unmeasured” risk factors for HIV infections in hyper-endemic communities in KwaZulu-Natal, South Africa
Handan Wand, Gita RamjeeARTICLEAIDS Care2015
Sub-Saharan Africa contains more than 60% of all HIV infections worldwide. HIV prevalence was currently estimated to be at least 15% in KwaZulu-Natal and the epidemic is described as hyper-endemic. Knowledge of spatial clustering of risk factors which are linked to new HIV infections is important for prioritizing areas to change the trajectory of the epidemic. Geoadditive models were used to investigate spatial characteristics of the risk factors…
Characteristics Associated with HIV Drug Resistance Among Women Screening for an HIV Prevention Trial in KwaZulu-Natal, South Africa
Open AccessBarbara S Mensch, Pamina M Gorbach et al.ARTICLEAIDS and Behavior2015
Baseline Predictors of High Adherence to a Coitally Dependent Microbicide Gel Based on an Objective Marker of Use
Open AccessBarbara Friedland, Marie C D Stoner et al.ARTICLEAIDS and Behavior2015
A randomized, placebo-controlled, efficacy trial of Carraguard was unable to demonstrate a reduction in women's risk of HIV infection, which may have been due, in part, to low adherence (gel used in 42 % of vaginal sex acts, on average). A secondary analysis was undertaken to understand baseline factors associated with high adherence (gel used in ≥85 % of sex acts). Women who reported ≥1 vaginal sex act, returned ≥1 opened applicator, and had ≥1 …
To tell or not to tell
Christine A Kelly, Barbara Friedland et al.ARTICLECulture Health & Sexuality2015
Gender norms that privilege men's sexual power and pleasure, and distrust of condom use in intimate relationships, leave women vulnerable to HIV and other sexually transmitted infections. Vaginal microbicides allow women to exert a degree of control over their sexual health, through responsibility for product insertion as well as the possibility of covert use. In practice, however, the uptake of new HIV-prevention products is heavily influenced b…
Women and HIV in Sub-Saharan Africa
Open AccessGita Ramjee, Brodie DanielsARTICLEAIDS Research and Therapy2013
Thirty years since the discovery of HIV, the HIV pandemic in sub-Saharan Africa accounts for more than two thirds of the world's HIV infections. Southern Africa remains the region most severely affected by the epidemic. Women continue to bear the brunt of the epidemic with young women infected almost ten years earlier compared to their male counterparts. Epidemiological evidence suggests unacceptably high HIV prevalence and incidence rates among …
Ethical Considerations in Determining Standard of Prevention Packages for HIV Prevention Trials
Open AccessBridget Haire, Morenike O Folayan et al.ARTICLEDeveloping World Bioethics2013
The successful demonstration that antiretroviral ( ARV ) drugs can be used in diverse ways to reduce HIV acquisition or transmission risks – either taken as pre‐exposure prophylaxis ( PrEP ) by those who are uninfected or as early treatment for prevention ( T4P ) by those living with HIV – expands the armamentarium of existing HIV prevention tools. These findings have implications for the design of future HIV prevention research trials. With the …
High prevalence of obesity among women who enrolled in HIV prevention trials in KwaZulu-Natal, South Africa
Open AccessHandan Wand, Gita RamjeeARTICLEBMC Public Health2013
Effective obesity prevention strategies are needed to re-formulate HIV prevention programmes by incorporating healthy diet and life style messages to target those who are at highest risk not just for HIV infection but also for non-communicable diseases
Geographical Clustering of High Risk Sexual Behaviors in “Hot-Spots” for HIV and Sexually Transmitted Infections in Kwazulu-Natal, South Africa
Open AccessGita Ramjee, Handan WandARTICLEAIDS and Behavior2013
We investigated geographical variations of three sexually transmitted infections (STIs) namely chlamydia, gonorrhea and syphilis in the greater Durban area, so as to optimize intervention strategies. The study population was a cohort of sexually active women who consented to be screened in one of three biomedical studies conducted in Durban. A total of nine local regions collectively formed three clusters at screening, five of which were previous…
Effects of Partnership Change on Microbicide Gel Adherence in a Clinical Trial (HPTN 035)
Open AccessPamina M Gorbach, Clifton W Kelly et al.ARTICLEAIDS and Behavior2013

Anal sex and HIV transmission in women
S S Karim, Salim S Abdool Karim et al.ARTICLEAmerican Journal of Public Health1998Citada por: 6Referencias: 12
Anal sex and HIV transmission in women. S S Karim, and G RamjeeCopyRight https://doi.org/10.2105/AJPH.88.8.1265-a Published Online: October 07, 2011
Microbicide acceptability research
Open AccessJoanne E Mantell, Landon Myers et al.ARTICLESocial Science & Medicine2005Citada por: 16Referencias: 39
We Have Our Protector”
Joanne E Mantell, Neetha S Morar et al.ARTICLEAmerican Journal of Public Health2006Citada por: 2Referencias: 12
Objectives. We examined perceptions of the effectiveness and acceptability of a candidate microbicide among 94 South African female sex workers who had participated in a phase 3 microbicide trial for HIV prevention. Methods. Sixteen focus groups were conducted in 2001, 12 to 15 months after participants were informed that the candidate microbicide had been determined to be ineffective in preventing HIV and other sexually transmitted infections (S…
The Use of the Diaphragm Instead of Condoms in a Phase III Diaphragm Trial
Open Accessthe MIRA Team, Ariane Van Der Straten et al.ARTICLEAIDS and Behavior2008
Acceptability and Use of the Diaphragm and Replens® Lubricant Gel for HIV Prevention in Southern Africa
Open Accessthe MIRA Team, Elizabeth Montgomery et al.ARTICLEAIDS and Behavior2009
The acceptability and use of the diaphragm and lubricant gel were assessed as part of a large randomized controlled trial to determine the effectiveness of the methods in women's HIV acquisition. 2,452 intervention-arm women were enrolled at five Southern African clinics and followed quarterly for 12-24 months. Acceptability and use data were collected by face-to-face interviews at Month 3 and Exit. Participants were "very comfortable" with the p…
Notes on the Frequency of Routinely Collected and Self-Reported Behavioral Data in HIV Prevention Trials
Open AccessDouglas Taylor, Douglas J Taylor et al.ARTICLEAIDS and Behavior2010
Combined Impact of Sexual Risk Behaviors for HIV Seroconversion Among Women in Durban, South Africa
Open AccessHandan Wand, Gita RamjeeARTICLEAIDS and Behavior2010
Assessing the Reporting of Adherence and Sexual Activity in a Simulated Microbicide Trial in South Africa
Open AccessBarbara S Mensch, Paul Hewett et al.ARTICLEAIDS and Behavior2010
User experiences and acceptability attributes of the diaphragm and lubricant gel in an HIV prevention trial in southern Africa
Nuriye Sahin‐Hodoglugil, Nuriye Nalan Sahin-Hodoglugil et al.ARTICLEAIDS Care2011
Methods for Improving Reproductive Health in Africa (MIRA), a phase III HIV prevention trial, was conducted among 5039 Zimbabwean and South African women to test the Ortho All-Flex diaphragm and Replens(®) lubricant gel. Among the 2418 intervention group participants, 105 women who had completed the trial and 41 male partners participated in focus group discussions and in-depth interviews about the acceptability of the diaphragm and gel and their…
Willingness of Clinicians to Integrate Microbicides into HIV Prevention Practices in Southern Africa
Open AccessCynthia C Harper, Kelsey Holt et al.ARTICLEAIDS and Behavior2011
HIV Incidence Among Non-Pregnant Women Living in Selected Rural, Semi-Rural and Urban Areas in Kwazulu-Natal, South Africa
Open AccessGita Ramjee, Handan Wand et al.ARTICLEAIDS and Behavior2011
The province of KwaZulu-Natal has the highest prevalence of HIV in South Africa, particularly among young women. In order to more closely examine the HIV prevalence and incidence in non-pregnant women from rural, semi-rural and urban areas, data from 5,753 women screened for enrolment into three HIV prevention studies were combined and analysed. The prevalence of HIV infection was 43% at screening. HIV incidence among the 2,523 enrolled HIV-negat…
Analyzing Continuous Measures in HIV Prevention Research Using Semiparametric Regression and Parametric Regression Models
Open AccessHandan Wand, Gita RamjeeARTICLEAIDS and Behavior2011
Assessing and evaluating the combined impact of behavioural and biological risk factors for HIV seroconversion in a cohort of South African women
Handan Wand, Gita RamjeeARTICLEAIDS Care2012
In this prospective study, we aimed to investigate and evaluate the impact of combinations of behavioural and biological risk factors on HIV acquisition in a cohort of women. Demographic, sexual and biologic risk factors including HIV seroconversion results from 1485 HIV negative women who were enrolled in a HIV prevention trial were used. First, Cox regression models were used to create a prediction model and weighted scoring system. Second, int…
Women and HIV in Sub-Saharan Africa
Open AccessGita Ramjee, Brodie DanielsARTICLEAIDS Research and Therapy2013
Thirty years since the discovery of HIV, the HIV pandemic in sub-Saharan Africa accounts for more than two thirds of the world's HIV infections. Southern Africa remains the region most severely affected by the epidemic. Women continue to bear the brunt of the epidemic with young women infected almost ten years earlier compared to their male counterparts. Epidemiological evidence suggests unacceptably high HIV prevalence and incidence rates among …
Ethical Considerations in Determining Standard of Prevention Packages for HIV Prevention Trials
Open AccessBridget Haire, Morenike O Folayan et al.ARTICLEDeveloping World Bioethics2013
The successful demonstration that antiretroviral ( ARV ) drugs can be used in diverse ways to reduce HIV acquisition or transmission risks – either taken as pre‐exposure prophylaxis ( PrEP ) by those who are uninfected or as early treatment for prevention ( T4P ) by those living with HIV – expands the armamentarium of existing HIV prevention tools. These findings have implications for the design of future HIV prevention research trials. With the …
High prevalence of obesity among women who enrolled in HIV prevention trials in KwaZulu-Natal, South Africa
Open AccessHandan Wand, Gita RamjeeARTICLEBMC Public Health2013
Effective obesity prevention strategies are needed to re-formulate HIV prevention programmes by incorporating healthy diet and life style messages to target those who are at highest risk not just for HIV infection but also for non-communicable diseases
Geographical Clustering of High Risk Sexual Behaviors in “Hot-Spots” for HIV and Sexually Transmitted Infections in Kwazulu-Natal, South Africa
Open AccessGita Ramjee, Handan WandARTICLEAIDS and Behavior2013
We investigated geographical variations of three sexually transmitted infections (STIs) namely chlamydia, gonorrhea and syphilis in the greater Durban area, so as to optimize intervention strategies. The study population was a cohort of sexually active women who consented to be screened in one of three biomedical studies conducted in Durban. A total of nine local regions collectively formed three clusters at screening, five of which were previous…
Effects of Partnership Change on Microbicide Gel Adherence in a Clinical Trial (HPTN 035)
Open AccessPamina M Gorbach, Clifton W Kelly et al.ARTICLEAIDS and Behavior2013
Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women
Jeanne Marrazzo, Jeanne M Marrazzo et al.ARTICLENew England Journal of Medicine2015
BACKGROUND: Reproductive-age women need effective interventions to prevent the acquisition of human immunodeficiency virus type 1 (HIV-1) infection. METHODS: We conducted a randomized, placebo-controlled trial to assess daily treatment with oral tenofovir disoproxil fumarate (TDF), oral tenofovir-emtricitabine (TDF-FTC), or 1% tenofovir (TFV) vaginal gel as preexposure prophylaxis against HIV-1 infection in women in South Africa, Uganda, and Zimb…
Spatial clustering of “measured” and “unmeasured” risk factors for HIV infections in hyper-endemic communities in KwaZulu-Natal, South Africa
Handan Wand, Gita RamjeeARTICLEAIDS Care2015
Sub-Saharan Africa contains more than 60% of all HIV infections worldwide. HIV prevalence was currently estimated to be at least 15% in KwaZulu-Natal and the epidemic is described as hyper-endemic. Knowledge of spatial clustering of risk factors which are linked to new HIV infections is important for prioritizing areas to change the trajectory of the epidemic. Geoadditive models were used to investigate spatial characteristics of the risk factors…
Characteristics Associated with HIV Drug Resistance Among Women Screening for an HIV Prevention Trial in KwaZulu-Natal, South Africa
Open AccessBarbara S Mensch, Pamina M Gorbach et al.ARTICLEAIDS and Behavior2015
Baseline Predictors of High Adherence to a Coitally Dependent Microbicide Gel Based on an Objective Marker of Use
Open AccessBarbara Friedland, Marie C D Stoner et al.ARTICLEAIDS and Behavior2015
A randomized, placebo-controlled, efficacy trial of Carraguard was unable to demonstrate a reduction in women's risk of HIV infection, which may have been due, in part, to low adherence (gel used in 42 % of vaginal sex acts, on average). A secondary analysis was undertaken to understand baseline factors associated with high adherence (gel used in ≥85 % of sex acts). Women who reported ≥1 vaginal sex act, returned ≥1 opened applicator, and had ≥1 …
To tell or not to tell
Christine A Kelly, Barbara Friedland et al.ARTICLECulture Health & Sexuality2015
Gender norms that privilege men's sexual power and pleasure, and distrust of condom use in intimate relationships, leave women vulnerable to HIV and other sexually transmitted infections. Vaginal microbicides allow women to exert a degree of control over their sexual health, through responsibility for product insertion as well as the possibility of covert use. In practice, however, the uptake of new HIV-prevention products is heavily influenced b…
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women
Jared M Baeten, Thesla Palanee‐phillip et al.ARTICLENew England Journal of Medicine2016
BACKGROUND: Antiretroviral medications that are used as prophylaxis can prevent acquisition of human immunodeficiency virus type 1 (HIV-1) infection. However, in clinical trials among African women, the incidence of HIV-1 infection was not reduced, probably because of low adherence. Longer-acting methods of drug delivery, such as vaginal rings, may simplify use of antiretroviral medications and provide HIV-1 protection. METHODS: We conducted a ph…
Sharing of Investigational Drug Among Participants in the Voice Trial
Open AccessJeeva Moodley, Sarita Naidoo et al.ARTICLEAIDS and Behavior2016